Der umfassende Leitfaden zum Genome Editing.
★
Menü
Startseite Lernen Neuigkeiten
Entdecken Technologien Krankheiten Behandlungen Klinische Studien Unternehmen Wissenschaftlerinnen und Wissenschaftler Gene Forschung Institutionen
Jenseits der Medizin Landwirtschaft Ethik Investieren Weltkarte
Lernen & Tools Hier starten Glossar A–Z Technologien vergleichen Zeitstrahl Listen & Rankings KI-Agenten ★ Gespeichert API
Über uns Über uns Methodik Datenquellen Redaktionelle Richtlinien Kontakt Haftungsausschlüsse

Geführte Ansicht
Neu in der Genetik? Wir erklären jeden Begriff beim Stöbern in einfacher Sprache. Dieselben Seiten, mit integrierter Hilfe.

Expertenansicht
Du kennst die Biologie bereits. Nur der Inhalt, klar und kompakt, ohne zusätzliche Erklärungen. Das ist die Standardansicht.

Sprache der Benutzeroberfläche
Heller Modus
A lone figure before a wall of streaming light

Die Karte der Genome-Editing-Revolution

Der CRISPR-CRISPR Decoded

Entdecke die Technologien, Behandlungen, Krankheiten, Wissenschaftlerinnen und Wissenschaftler, Unternehmen, klinischen Studien und Entdeckungen, die die Zukunft der Genmedizin gestalten.

15 treatments tracked 14 clinical trials Bildungsreferenz · nur zu Forschungszwecken · niemals medizinischer Rat
You are in Guided View. Terms are explained as you go, and every page opens with a plain-language summary before the technical detail. Switch back to Expert View from the menu at any time.

Dort einsteigen, wo Sie wirklich stehen

Diese Website richtet sich gleichzeitig an sehr unterschiedliche Leserinnen und Leser. Jeder Einstieg unten führt aus einem anderen Blickwinkel in dieselbe Datenbank. Nichts wird vereinfacht, und nichts setzt ein Biologiestudium voraus.

A child's hands holding a small glowing DNA ladder New to all of thisBeginnen Sie mit dem, was DNA ist, und bauen Sie darauf auf. Keine Vorkenntnisse erforderlich. A doctor and a patient talking across a desk A patient or familyWas zugelassen ist, was sich noch in Studien befindet und wie man den Unterschied erkennt. Nested glowing rectangles receding into darkness Die Branche im BlickWer was in welcher Phase entwickelt. Information, niemals Beratung. Rows of seedlings under purple grow lights Hier für Lebensmittel und LandwirtschaftGentechnisch veränderte Nutzpflanzen und Nutztiere und warum die Regeln je nach Land unterschiedlich sind.

Genomeditierung entdecken

Sieben Wege, wie Wissenschaftlerinnen und Wissenschaftler genetisches Material verändern. Jede Seite beginnt mit einer verständlichen Erklärung und geht dann so tief, wie du möchtest.

Alle Technologien →
the crystal structure of Streptococcus pyogenes Cas9 in complex with sgRNA and its target DNA at 2.5 A ˚ resolution CRISPR-Cas9A protein that can be programmed with a short RNA guide to find one specific sequence in a genome and cut it. Hiroshi Nishimasu, F. Ann Ran,... · CC BY-SA 3.0 A DNA helix with one letter being chemically changed Base EditingChemically converts one DNA letter into another at a chosen position, without cutting both strands of the double helix. A prime editor writing new letters into a DNA strand Prime EditingWrites a new stretch of DNA sequence directly into a chosen site, using a guide that carries the replacement text with it. A Cas12 enzyme on DNA, scattering fragments CRISPR-Cas12A family of CRISPR nucleases that cut DNA leaving staggered ends, use a different sequence requirement from Cas9, and can be smaller. A Cas13 enzyme cutting a strand of RNA CRISPR-Cas13Targets RNA rather than DNA, so it can silence a gene's message without touching the genome itself. A tiny Cas14 enzyme bound to a DNA helix Cas14 and miniature Cas systemsUnusually small CRISPR nucleases, roughly a third the size of Cas9, discovered in archaea and bacteriophages. An enzyme changing a letter on a strand of RNA RNA EditingChanges letters in the RNA message rather than in the DNA, so the effect is real but temporary and the genome is untouched. Two molecular structures side by side, linked by threads of light Nebeneinander vergleichenPräzision, Schnitt, Frachtgröße, Lieferung, Reifegrad, Risiken

Behandelte Krankheiten

Jede Krankheitsseite erklärt klar und deutlich, ob Genomeditierung eine zugelassene Behandlung ist, sich in klinischen Studien befindet oder noch ausschließlich ein Laborkonzept ist.

Alle Krankheiten →
Blood smear from a patient with sickle cell anemia displaying sickle cells, polychromasia, and target cells Sickle Cell DiseaseBlood disorders SpicyMilkBoy · CC BY-SA 4.0 A giemsa stained blood smear from a person with beta thalassemia Beta ThalassemiaBlood disorders Dr Graham Beards · CC BY-SA 4.0 Fibrous amyloid deposits wrapped around heart muscle ATTR AmyloidosisMetabolic disease Swollen right hand in a female patient during a hereditary angioedema attack. Hereditary angioedema Hereditary AngioedemaRare genetic disease LucyHAE · CC BY-SA 3.0 A liver and an artery cross-section with lipoprotein particles High Cholesterol and Familial HypercholesterolemiaCardiovascular disease Micrograph of a nodular basal cell cancer with a cleft. H&E stain. Such clefts are caused by shrinkage of mucin during tissue fixation and staining. Robert S Bader. Which histologi CancerCancer Mikael Häggström, M.D. Author info... · CC0 Blood smear showing acute lymphatic leukaemia (Jenner's stain). Wellcome Images Keywords: Clinical Medicine; Goodall; Haematology; Guilland; Leukaemia Leukemia and LymphomaCancer https://wellcomeimages.org/indexplu... · CC BY 4.0 This scanning electron micrograph revealed the presence of the human immunodeficiency virus (HIV-1), (spherical in appearance), which had been co-cultivated with human lymphocytes. HIVInfectious disease Photo Credit: C. Goldsmith Content... · Public domain Histopathology of gastrocnemius muscle from patient who died of pseudohypertrophic muscular dystrophy, Duchenne type. Cross section of muscle shows extensive replacement of muscle Duchenne Muscular DystrophyMuscular disease Dr. Edwin P. Ewing, Jr. · Public domain A cross-section of an airway clogged with thick mucus Cystic FibrosisRare genetic disease

Behandlungen

Namentlich genannte Medikamente, mit Zulassungsstatus auf jedem Eintrag.

Casgevy (exagamglogene autotemcel)The first CRISPR-based medicine approved anywhere in the world: a one-time therapy made from a patient's own edited blood stem cells. Approved Lyfgenia (lovotibeglogene autotemcel)Approved on the same day as Casgevy for sickle cell disease, but a gene-addition therapy, not gene editing, which makes the pair a useful comparison. Approved Zynteglo (betibeglogene autotemcel)An approved gene-addition therapy for transfusion-dependent beta thalassemia: the non-editing alternative to Casgevy in the same disease. Approved Nexiguran ziclumeran (nex-z)The first CRISPR therapy ever administered into a human bloodstream: a single infusion intended to switch off the TTR gene in the liver for good. Phase III Lonvoguran ziclumeran (lonvo-z)The first in vivo gene-editing therapy to report a positive Phase 3 result: a single infusion intended to stop hereditary angioedema attacks permanently. Phase III Risto-cel (BEAM-101)A base-editing therapy for sickle cell disease that mimics a naturally protective genetic variant, with a licence application signalled for as early as the end of 2026. Phase III

Zugelassene Medikamente in CRISPR Decoded: Casgevy (exagamglogene autotemcel) · Lyfgenia (lovotibeglogene autotemcel) · Zynteglo (betibeglogene autotemcel)

Alle Behandlungen →

Klinische Studien

Wo die Belege tatsächlich entstehen.

4Rekrutierend
2Aktiv, keine Aufnahme
7Abgeschlossen
CLIMB SCD-121: the trial that led to the first CRISPR medicine approvalSickle cell disease · NCT03745287 Phase II/III CLIMB THAL-111: the beta thalassemia trial behind the Casgevy approvalBeta thalassemia · NCT03655678 Phase II/III MAGNITUDE: Phase 3 in vivo CRISPR for ATTR cardiomyopathyATTR amyloidosis · NCT06128629 Phase III MAGNITUDE-2: Phase 3 in vivo CRISPR for ATTR polyneuropathyATTR amyloidosis · NCT06672237 Phase III HAELO: the first positive Phase 3 result for in vivo gene editingHereditary angioedema · NCT06634420 Phase III BEACON: base editing for sickle cell diseaseSickle cell disease · NCT05456880 Phase I/II

Die Studiendatenbank durchsuchen →

Wichtige Unternehmen

Wer was aufbaut und wie weit jedes Programm fortgeschritten ist.

Alle Unternehmen →
CRISPR TherapeuticsCRSP · Zug, Switzerland Intellia TherapeuticsNTLA · Cambridge, Massachusetts Beam TherapeuticsBEAM · Cambridge, Massachusetts Editas MedicineEDIT · Cambridge, Massachusetts Prime MedicinePRME · Cambridge, Massachusetts Verve TherapeuticsPrivat · Boston, Massachusetts Caribou BiosciencesCRBU · Berkeley, California Sana BiotechnologySANA · Seattle, Washington

Wissenschaftlerinnen und Wissenschaftler, die das Feld verändert haben

Was jede Person tatsächlich beigetragen hat. Die Zuschreibung von Verdiensten ist in diesem Feld umstritten, und wir geben an, wo das der Fall ist.

Alle Wissenschaftlerinnen und Wissenschaftler →
Jennifer Doudna in 2021 at the Innovative Genomics Institute by Christopher Michel Jennifer DoudnaStructural biochemist who, with Emmanuelle Charpentier, showed that Cas9 could be programmed with a single guide RNA to cut chosen DNA, and shared the 2020 Nobel Prize in Chemistry for it. Christopher Michel · CC BY-SA 4.0 Director, Max Planck Institute for Infection Biology, Department of Regulation in Infection Biology. Visiting professor The Laboratory for Molecular Infection Medicine Sweden MIMS; Emmanuelle CharpentierMicrobiologist who discovered tracrRNA, the missing component of the CRISPR-Cas9 system, and shared the 2020 Nobel Prize in Chemistry with Jennifer Doudna. Bianca Fioretti, Hallbauer & Fioretti · CC BY-SA 4.0 Prof. Feng Zhang at the Forbes 30 Under 30 Summit, Boston MA. 2017 Feng ZhangBioengineer who led one of the first demonstrations of CRISPR genome editing in human cells and discovered several new CRISPR systems including Cas12a and Cas13. PuppyEggs · CC BY-SA 4.0 David R. Liu, chemist, 2012 photo David LiuChemical biologist whose laboratory invented base editing and prime editing, the two techniques that changed gene editing from cutting to writing. ServiceAT · CC BY-SA 4.0 George Church in 2023 George ChurchGeneticist whose laboratory independently demonstrated CRISPR editing in human cells in 2013, and a founder of an unusually large number of genomics companies. Christopher Michel · CC BY-SA 4.0 Prof. Virginijus Šikšnys Virginijus ŠikšnysLithuanian biochemist who independently showed that Cas9 could be programmed to cut DNA, publishing in 2012, and whose contribution is often omitted from popular accounts. Gie2016 · CC BY-SA 4.0

Aktuelle Gene-Editing-Nachrichten

Echte Artikel von namentlich genannten Verlagen. Jede Überschrift verlinkt auf das Original. Wir schreiben sie nie um und veröffentlichen sie nicht neu.

Alle Neuigkeiten →
Backed by Amish and Mennonites, a new kind of gene therapy company takes shape LANCASTER, PA — This spring, Lorraine and Mark Martin, a Mennonite family with a tax business, adopted a stubby-legged cow named Royal Lite. Lorraine… Endpoints News Treatments 57 min ago↗ Rice plants can fight off devastating disease after gene editing with AI-designed tool University of Missouri researchers have created rice plants that resist bacterial blight, a devastating disease that threatens one of the world's most… Phys.org — Molecular Biology Agriculture 1h ago↗ STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases. STAT Treatments 3h ago↗ Bonjour Genomics: A Video from ASHG GEN editors Uduak Thomas and Julianna LeMieux, PhD, recap ASHG, highlighting key sessions, Ultima Genomics’ user group meeting, Illumina news, and… GEN — Genetic Engineering News Companies 4h ago↗ Artiva to wind down after two patient deaths in autoimmune cell therapy trials Cell therapy biotech Artiva Biotherapeutics abruptly announced Tuesday morning that it is effectively shutting down and laying off almost all of its staff… Endpoints News Clinical Trials 7h ago↗ Outpace ends an ovarian cancer trial; Incyte data impresses at ESMO Plus news about Genmab, Rumi, Prana and Fractyl. Outpace Bio ends cell therapy trial: The Seattle startup canned a Phase 1 ovarian cancer trial of its… Endpoints News Clinical Trials 7h ago↗ STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is… STAT Treatments 7h ago↗ Spatial Proteomics for Precision Oncology In this GEN webinar, Bernd Bodenmiller, PhD (University of Zürich), illustrates this integrated approach through two recent examples. The post Spatial… GEN — Genetic Engineering News Companies 1d ago↗

CRISPR erklärt

Ganz von vorne anfangen. Kein biologisches Vorwissen nötig.

Lernen beginnen →
What is DNA?DNA is a long chemical chain that stores the instructions for building and running a living… What is a gene?A gene is a stretch of DNA that carries the instructions for making one particular thing the… What is a chromosome?A chromosome is one very long DNA molecule packaged with proteins; humans normally have 46, in… What is a genome?A genome is the complete set of genetic instructions in an organism: every chromosome, every… What is RNA?RNA is DNA's working copy: a temporary, single-stranded version the cell makes when it needs to… What is a mutation?A mutation is a change in DNA sequence. Most do nothing, some cause disease, and a few are…
An open journal, a magnifying glass and a molecular model under a desk lamp Die Forschung dahinter Wegweisende Facharbeiten in verständlicher Sprache zusammengefasst, jeweils mit Link zur Originalpublikation. A vintage microscope and a chain of glowing milestones Die Geschichte des Genome Editings Von der Struktur der DNA bis zum ersten zugelassenen CRISPR-Medikament: die Ereignisse, die uns hierher geführt haben.
A farmhouse on a ploughed field at sunset LandwirtschaftNutzpflanzen, Nutztiere und die je nach Land unterschiedlichen Regelungen Two empty chairs facing each other with a balance scale above EthikDie Argumente, von beiden Seiten dargestellt A city skyline through a window with a glowing chart overlay InvestierenWie diese Branche finanziert wird: Informationen, keine Beratung The Earth at night with glowing connection lines WeltkarteWo Gen-Editing stattfindet
Bevor du weiterliest Der CRISPR-CRISPR Decoded ist ein Bildungsangebot. Er bietet keine medizinische Beratung, und Informationen über eine experimentelle Therapie sind kein Beleg dafür, dass diese Therapie sicher oder wirksam ist. Der Status klinischer Studien und behördlicher Zulassungen ändert sich häufig. Wenn es um eine Entscheidung zu Ihrer eigenen Gesundheit oder der eines Familienmitglieds geht, sprechen Sie bitte mit einer qualifizierten medizinischen Fachkraft. Die vollständigen Haftungsausschlüsse lesen →